Abstract: The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). The compounds of the invention are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.

Abstract: The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.

Abstract: The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.

Abstract: The invention relates to compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (TRPM8), and having formula (I). Said compounds are useful in the treatment of diseases associated with activity of TRPM8 such as pain, inflammation, ischaemia, neurodegeneration, stroke, psychiatric disorders, itch, irritable bowel diseases, cold induced and/or exacerbated respiratory disorders and urological disorders.

Abstract: A method for destroying asbestos in mainly organic matrix asbestos-containing waste includes the steps of: preparing the asbestos-containing waste; preparing a supercritical aqueous phase; letting the asbestos and the primarily organic matrix of the asbestos-containing waste react with the aqueous phase for a time t in an appropriate reactor at a predetermined pressure P and temperature T to maintain the aqueous phase in supercritical condition; cooling and condensing the aqueous phase flowing out of the reactor; and separating the aqueous phase from any entrained solid products therein. The step of preparing the supercritical aqueous phase includes an additional step, in which an oxidizing compound is added in a predetermined concentration Cl, the pressure P is in a range from 25 to 27 MPa, and the temperature T is in a range from 600° C. to 650° C., causing the asbestos and the organic binder to be simultaneously destroyed.

Abstract: A method for destroying asbestos in mainly organic matrix asbestos-containing waste (ACW), which includes the steps of: preparing the asbestos-containing waste; preparing a supercritical aqueous phase; allowing asbestos and the primarily organic matrix of the asbestos-containing waste to react with the aqueous phase for a time t in an appropriate reactor at predetermined pressure P and temperature T to maintain the aqueous phase in supercritical conditions; cooling and condensing the aqueous phase flowing out of the reactor; and separating said aqueous phase from any entrained solid product therein. The step in which the supercritical aqueous phase is prepared includes an additional step, in which at least one oxidizing compound is added in a predetermined concentration C1, the pressure P is in a range from 25 to 27 MPa, and the temperature T is in a range from 600° C. to 650° C., causing the asbestos and the organic binder to be simultaneously destroyed.

Abstract: Amidines and derivatives thereof of formula (I) are described. The process for their preparation and pharmaceutical compositions thereof are also described. The amidines of the invention are useful in the inhibition of chemotaxis of neutrophils induced by IL-8. The compounds of the invention are used in the treatement of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.

Abstract: Amidines and derivatives thereof of formula (I) are described. The process for their preparation and pharmaceutical compositions thereof are also described. The amidines of the invention are useful in the inhibition of chemotaxis of neutrophils induced by IL-8. The compounds of the invention are used in the treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.